Adverse Effects of Antiretroviral Therapy
Lancet 356:1423-1430, Carr,A. &Cooper, D.A., 2000
Confused About Confusion
NEJM 386:80-87, Spanjaart, A.M.,et al, 2022
Varicella-Zoster Virus Infections in Patients Treated with Fingolimod
JAMA Neurol 72:31-39,10, Arvin, A.M.,et al, 2015
Prevalence and Distribution of VZV in Temporal Arteries of Patients with Giant Cell
Neurol 84:1948-1955, Gilden, D.,et al, 2015
Impact of Late Diagnosis and Treatment on Life Expectancy in People with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
BMJ 343:d6016,d6015, May, M.,et al, 2011
Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009
A 70-Year-Old Woman with Shingles: Review of Herpes Zoster
JAMA 302:73-80,108, Whitley,R.J., 2009
Changes in the Incidence and Predictors of Human Immunodeficiency Virus-Associated Dementia in the Era of Highly Active Antiretroviral Therapy
Ann Neurol 63:213-221, Bhaskaran,K.,et al, 2008
HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998
Risk Factors for Postherpetic Neuralgia
Arch Int Med 157:1217-1224, 11661997., Choo,P.W.,et al, 1997
Postherpetic Neuralgia-Pathogenesis, Treatment and Prevention
NEJM 335:32-42, Kost,R.G.&Straus,S.E., 1996
Cytomegalovirus Encephalitis
Ann Int Med 125:577-578, Arribas,J.R.,et al, 1996
2', 3'-Dideoxycytidine (ddC) Toxic Neuropathy:A Study of 52 Patients
Neurol 43:358-362, Berger,A.R.,et al, 1993
Therapy for Human Immunodeficiency Virus Infection
NEJM 328:1686-1695, Hirsch,M.S.&D'Aquila,R., 1993
Herpes Simplex & the Human Nervous System
Milit Med 140:765, Finelli,P.F., 1975
Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir
Ann Neurol 93:88-102, Grundmann,A.,et al, 2023
Congenital Cytomegalovirus Infection
BMJ 373:m1212, Pesch, M.H.,et al, 2021
Clinicopathologic Conference, HIV Type 2 Infection & Cerebral Toxoplasmosis
NEJM 383:859-866, Case 27-2020, 2020
Clinicopathologic Conference, Human Herpesvirus 6-Related Meningoencephalitis
NEJM 378:659-669, Case 5-2018, 2018
HIV Testing and Management of Newly Diagnosed HIV
BMJ 349:g4275, Rayment, M.,et al, 2014
Preexposure Prophylaxis for HIV - Where Do We Go from Here?
NEJM 367:459-461,462, Cohen, M.S. & Baden, L.R., 2012
Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
NEJM 365:493-505,561, Cohen, M.S.,et al, 2011
PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009
Clinicopath Conf, Acute HIV-1 Infection
NEJM 360:1540-1548, Case 11-2009, 2009
Steroid and Antiviral Treatment for Bells Palsy
Lancet 371:1818-1820, Hato,N.,et al, 2008
Reversible Posterior Leukoencephalopathy Syndrome in 2 HIV-Infected Patients Receiving Antiretroviral Therapy
CID 49:e19-e22, Ridolfo, A.L.,et al, 2008
Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine
AJNR 26:695-701,687, Tardieu,M.,et al, 2005
Vasculitic Mononeuritis Multiplex Induced by Valcyclovir
Neurol 62:1906-1907, Pary,L.F.,et al, 2004
Recurrent Meningitis of Unknown Aetiology
Lancet 363:1772, Ellerin,T.B.,et al, 2004
HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001
Therapeutic Dilemma
Neurol 54:1404-1407, Romanelli,F.,et al, 2000
Clinicopath Conf
Subacute Sclerosing Panencephalitis, Case 15-1998, NEJM 338:1448-1456998., , 1998
Lipodystrophy Associated with an HIV-Protease Inhibitor
NEJM 339:1296, Carr,A.&Cooper,D.A., 1998
Buffalo Hump in a Patient with the Acquired Immunodeficiency Syndrome
NEJM 339:1297, Aboulafia,D.M.&Bundow,D., 1998
HIV-1 Protease Inhibitors
JAMA 227:145-149, Deeks,S.J.,et al, 1997
Hearing Loss and Antiretroviral Therapy in Patients Infected with HIV-1
Arch Neurol 54:407-410, Marra,C.M.,et al, 1997
The Effect of Treating Herpes Zoster with Oral Acyclovir in Preventing Postherpetic Neuralgia
Arch Int Med 157:909-912, Jackson,J.L.,et al, 1997
Neurologic Prognosis of Cytomegalovirus Polyradiculomyelopathy in AIDS
Neurol 43:493-499, Cohen,B.A.,et al, 1993
Acyclovir-Induced Neurotoxicity:Concentration-Side Effect Relationship in Acyclovir Overdose
Am J Med 94:212-215, Haefeli,W.E.,et al, 1993
Mortality in Patients with AIDS Treated with Either Foscarnet or Ganciclovir for CMV Retinitis
AIDS Res Group & AIDS Clin Trials Group, NEJM 326:213-220, 2642., , 1992
Central Nervous System Side Effects of Ganciclovir
NEJM 322:933-934, Davis,C.L.,et al, 1990
Ganciclovir in the Treatment of Progressive AIDS-Related Polyradiculopathy
Neurol 40:569-574, Miller,R.G.,et al, 1990
Drugs Five Years Later:Acyclovir
Ann Int Med 107:859-874, Dorsky,D.I.&Crumpacker,C.S., 1987
Infections with Herpes Simplex Viruses
NEJM 314:686-691, 749-7571986., Corey,L.&Spear,P.G., 1986
Acute Herpetic & Postherpetic Neuralgia:Clinical Review & Current Management
Ann Neurol 20:651-664, Portenoy,R.K.,et al, 1986
Prevention Of Reactivated Herpes Simplex Infection By Human Leukocyte Interferon After Operation On The Trigeminal Root
NEJM 301:225-230, Paxin,G.J.,et al, 1979